IHS was saddened to learn of the death of Professor Ottar Sjaastad from Norway, who founded Cephalalgia in 1981

Applications are invited to assume the role of Editor-in-Chief of Cephalalgia from January 2025. Application deadline 9 January 2023

Submit your trigeminal pain study protocol to Cephalalgia Reports and the final results to Cephalalgia

Last published in 1995, the IHS is pleased to publish updated Guidelines for Controlled Clinical Trials in Cluster Headache. Freely available to read in Cephalalgia.

IHS members interview the authors of articles on headache provocation by nitric oxide and visual autonomic symptoms in migraineurs

2021 Cephalalgia impact factor is 6.075

IHS grants have assisted many young researchers in building an academic and clinical career in the field of headache

We are delighted to announce that the Impact Factor for Cephalaliga for 2020 has increased from 4.868 to 6.292.